{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:39:37Z","timestamp":1789886377451,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.cca.2017.12.041","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T20:28:41Z","timestamp":1514320121000},"page":"166-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Galectin-3 in patients with coronary heart disease and atrial fibrillation"],"prefix":"10.1016","volume":"478","author":[{"given":"Qi","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4000-8432","authenticated-orcid":false,"given":"XiaoLong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taniya","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2017.12.041_bb0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0008-6363(02)00258-4","article-title":"Electrical, contractile and structural remodeling during atrial fibrillation","volume":"54","author":"Allessie","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2017.12.041_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/CIRCIMAGING.109.865683","article-title":"Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI","volume":"3","author":"Kuppahally","year":"2010","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.cca.2017.12.041_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.cca.2017.12.041_bb0020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cellbi.2006.11.036","article-title":"Expression and immunohistochemical localization of Galectin-3 in various mouse tissues","volume":"31","author":"Kim","year":"2007","journal-title":"Cell Biol. Int."},{"issue":"16","key":"10.1016\/j.cca.2017.12.041_bb0025","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.cca.2017.12.041_bb0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/glycob\/cwt006","article-title":"Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"23","author":"MacKinnon","year":"2013","journal-title":"Glycobiology"},{"issue":"3","key":"10.1016\/j.cca.2017.12.041_bb0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/ATVBAHA.114.304964","article-title":"Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease","volume":"35","author":"Maiolino","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.cca.2017.12.041_bb0040","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/039463201102400409","article-title":"Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome","volume":"24","author":"Falcone","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"4","key":"10.1016\/j.cca.2017.12.041_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4070\/kcj.2013.43.4.223","article-title":"Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis","volume":"43","author":"Lee","year":"2013","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.cca.2017.12.041_bb0050","first-page":"56","article-title":"Galectin-3 as a predictor of statin treatment efficacy in patients with multiple myeloma","volume":"255","author":"Samura","year":"2016","journal-title":"Georgian Med. News"},{"key":"10.1016\/j.cca.2017.12.041_bb0055","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"de Boer","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cca.2017.12.041_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2014.10.009","article-title":"Galectin-3 and heart failure: prognosis, prediction and clinical utility","volume":"443","author":"Filipe","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2017.12.041_bb0065","article-title":"LBOS 02\u201303 the infiltrating macrophage-secreted galectin-3 plays an essential role in cardiac fibrosis and diastolic function in murine pressure-overload model","volume":"34","author":"Chen","year":"2016","journal-title":"J. Hypertens."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117305417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117305417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T11:05:26Z","timestamp":1528974326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117305417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":13,"alternative-id":["S0009898117305417"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.12.041","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galectin-3 in patients with coronary heart disease and atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}